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Available online 12 July 2016Pneumococcal meningitis is the most common and severe form of bacterial meningitis. Early recognition of the
pathogen and subsequent innate immune response play a vital role in disease susceptibility and outcome. Genet-
ic variations in innate immune genes can alter the immune response and inﬂuence susceptibility and outcome of
meningitis disease.
Here we conducted a sequencing study of coding regions from 46 innate immune genes in 435 pneumococcal
meningitis patients and 416 controls, to determine the role of genetic variation on pneumococcalmeningitis sus-
ceptibility and disease outcome.
Strongest signals for susceptibility were rs56078309 CXCL1 (p = 4.8e−04) and rs2008521 in CARD8 (p =
6.1e−04). For meningitis outcome the rs2067085 in NOD2 (p = 5.1e−04) and rs4251552 of IRAK4 were the
strongest associations with unfavorable outcome (p = 6.7e−04). Haplotype analysis showed a haplotype
block, determined by IRAK4 rs4251552, signiﬁcantly associatedwith unfavorable outcome (p=0.004). Cytokine
measurements from cerebrospinal ﬂuid showed that with the IRAK4 rs4251552 G risk allele had higher levels of
IL-6 compared to individuals with A/A genotype (p = 0.04).
We show that genetic variation within exons and ﬂanking regions of 46 innate immunity genes does not yield
signiﬁcant association with pneumococcal meningitis. The strongest identiﬁed signal IRAK4 does imply a poten-
tial role of genetic variation in pneumococcal meningitis.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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NOD21. Introduction
Community-acquiredmeningitis is a life-threatening infection of the
membranes surrounding the brain and spinal cord. Pneumococcalmen-
ingitis is the most common and severe form of bacterial meningitis. Fa-
tality rates are substantial, and long-term sequelae develop in about halfiscovery Rate; GATK, genome
dy–Weinberg equilibrium; IPD,
MAF, minor allele frequency;
eptors; NRLBM, Netherlands
dds ratio; PAMPS, pathogen-
e chain reaction; RVIS, residual
rnel Association Test; TLR, Toll-
enter of Infection and Immunity
ersity of Amsterdam, P.O. Box
eek).
. This is an open access article underof survivors (Brouwer et al., 2010; Schut et al., 2012; van de Beek et al.,
2012; van de Beek et al., 2004; Zoons et al., 2008). Vaccination has de-
creased the incidence of invasive pneumococcal disease in infants and
recently also in the adult population (Bijlsma et al., 2016; McIntyre et
al., 2012; Tsai et al., 2008).
Streptococcus pneumoniae is a human commensal strain adapted to
colonize the nasopharynx (Brown et al., 2015). However, after asymp-
tomatic colonization translocation of the pneumococcus to the respira-
tory tract, sinuses and nasal cavity, S. pneumoniae can cause pneumonia,
acute sinusitis, otitis media, bacteremia, sepsis and meningitis (Brown
et al., 2015; Mook-Kanamori et al., 2011; van de Beek et al., 2006).
One of the ﬁrst host determinants of developing an infection is the rec-
ognition and clearance of the pneumococcal strains with initiation of an
inﬂammatory response by the innate immune response. The innate im-
mune response depends on speciﬁc pathogen-associatedmolecular pat-
tern molecules (PAMPS) of the pneumococcus. For example,
peptidoglycan and lipoteichoic acid (LTA), are recognized bymembranethe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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cells (Santos-Sierra et al., 2006). After PAMP recognition, intracellular
signaling initiates the activation of transcription factors. This leads to
the induction of small cell signaling proteins, called cytokines, which
are responsible for the inﬂammatory response and attracts immune
cells to the site of infection (Akira et al., 2006). TLRs, like TLR2, TLR4,
TLR9 and NOD-like receptors (NLRs) as NOD2 are known to be impor-
tant in the recognition of invasive pneumococcal strains (Koppe et al.,
2012). Differenceswithin these or underlying signaling proteins, caused
by genetic variations, can contribute to differences in the immune re-
sponse affecting the susceptibility to disease and its severity.
Genetic variations TLR4, TIRAP, NFKBIA and NFKBIB, TNF, IL10, IL-6,
IRAK4 and IKBKG have been previously described to inﬂuence suscepti-
bility to invasive pneumococcal disease (Brouwer et al., 2009; Chapman
et al., 2007). The role of genetic variation in innate immune genes in
pneumococcal meningitis and its effect on disease outcome is less well
known. In this study, we sequenced the exons and ﬂanking intron bor-
ders of all known genes that are important in innate immune signaling
pathway in a pneumococcal meningitis patient population for which
detailed clinical data has been collected. This gives us the opportunity
to study association of innate immune gene variation with disease sus-
ceptibility and outcome, and to gain further insight in the role of genetic
variation in the innate immune system during pneumococcal
meningitis.
2. Material and Methods
2.1. Dutch Bacterial Meningitis Cohort
In a nationwide prospective cohort study (MeninGene) we included
adult patients, age of 16 years and older, with community-acquired bac-
terial meningitis with positive CSF cultures who were identiﬁed by the
Netherlands Reference Laboratories for Bacterial Meningitis (NRLBM).
The cohort and inclusion procedure is described elsewhere (Bijlsma et
al., 2016).
A total of 1300 patients and partners or non-related proxies, living in
the same residence, used as controls included during 2006 and 2011,
were included in this study. Patient data were collected in an online
case record form and included presenting characteristics, treatment,
complications and outcome. Patient outcome was graded at discharge
according the Glasgow Outcome Scale (GOS) (Jennett et al., 1976). A
score of one on this ﬁve point scale indicates death, score of two vegeta-
tive state, score three severe disability, score four moderate disability,
and a score of ﬁvemild or no disability. We considered a score of 5 a fa-
vorable outcome and scores 1 to 4 were deﬁned as unfavorable
outcome.
Blood for DNA extraction was withdrawn from the patients and col-
lected in sodium/EDTA tubes. Isolation of the DNAwas performed with
the Gentra Puregene isolation kit (Qiagen) according to manufacturer's
protocol, thereafter the yield and quality of the extractions were deter-
mined to ensure appropriate conditions for genotyping.
2.2. Ethical Approval
This study was approved by the ethics committee of the Academic
Medical Center, Amsterdam, the Netherlands. Informed consent was
obtained from all participating individuals or legally authorized repre-
sentatives. The study was conducted according to the principles of the
Declaration of Helsinki (version of 2013. Fortaleza, Brazil) and in accor-
dancewith theMedical Research InvolvingHuman Subjects Act (WMO)
and other guidelines, regulations and acts.
2.3. Marker Selection
Forty-six innate immune genes were selected for exome sequencing
(Supplementary Table 1). Inclusion criteriawere: (1) geneswith knowninvolvement of pneumococcal recognition, (2) genes with variations
that have previously been associated with invasive pneumococcal dis-
ease and meningitis and (3) genes that encode for related downstream
signaling and transcription proteins in the TLR, NOD and inﬂammasome
signaling pathways. This led to the inclusion of 46 innate immune genes
(Supplement Table 1).
2.4. Solid Sequencing
DNA concentration was determined by means of ﬂuorometric mea-
surement (Qubit, Thermo) and quality was checked by means of deter-
mining the absence of degradation and presence of High Molecular
weight DNA. Circa 1,5 μg DNA was sheared by sonication followed by
barcoded adaptor ligated library construction, using the Biomek FX auto-
mated liquid handler (Beckman Coulter). Solid fragment Library prepara-
tion kit and solid barcoded adaptors were used according manufacturers
protocol (Life Technologies, 5500 SOLID™ Fragment Library Core Kit, Cat-
alog number 4464412). Each sample was generated using a separate
10 bp barcode incorporated in the adaptor sequence. After 8 cycles of am-
pliﬁcation using the library prep kit supplied PCR primers, PCR mix and
PCR protocol and puriﬁed twice-using ampure. Two rounds of hybridiza-
tion capture was performed using a Custom Complement Capture
(Nimblegen, pn 130204_HG19_CompCapV2_MJ_EZ_HX3). Equimolar
pooling of the captured libraries was based on concentration and average
sample size. Emulsion PCRwas performed using the Solid EZ Bead Emul-
siﬁer and Ampliﬁer (Applied Biosystems). Sequencingwas performed on
the Solid 5500xl sequencer (Life technologies) generating paired-end
reads (50 bp forward and 35 bp reverse).
2.5. Alignment and Variation Calling Pipeline
Paired-end reads for each individualweremerged using Picard (ver-
sion 1.92) and aligned to the GRch37/HG19 reference genome using the
Lifescope aligner (version 2.5.1, Applied Biosystems). To minimize mis-
matched bases between reads, realignment was performed using the
RealignerTargetCreator function in GATK (version 2.7-4) using the in-
tervals from Mills_and_1000G_gold_standard.indels.hg19.vcf. Mate in-
formation can be changed during realignment and changes were ﬁxed
using Picard. Samples were recalibratedwith GATK Recalibrate and var-
iants were called using GATKs HaplotypeCaller (version 3.3-0) with de-
fault settings and only adjusting the minimal mapping quality score to
30. Variantswere then ﬁltered on aminimal read depth of 20, allele bal-
ance between 0.2 and 0.8 for heterozygotes, N0.9 for homozygotes and
genotype quality of 99. After ﬁltering, all samples were combined and
genotyped by using GATK CombineGVCFs and GenotypeGVCFs (version
3.3-0) and converted to PLINK (Chang et al., 2015). Finally, all chromo-
somal locations for found variants were annotated using SnpEff and the
UCSC variant annotation integrator tool (https://genome.ucsc.edu/)
(Cingolani et al., 2012).
2.6. Variants and Sample QC
After alignment and variation calling, we removed all individuals of
whichwe found that there was a third, or higher, degree of relatedness.
Reported ancestry was used to exclude non-European ancestry to ac-
count for population stratiﬁcation. Because the ancestry was reported
we also evaluated the effect of ancestry for all common variants
(MAF ≥ 0.01) by calculating themultidimensional scaling (MDS) analy-
sis with PLINK and including them as covariates.
All individuals with missingness of 5% or heterozygosity above or
below 3 standard deviations from themeanwere removed. Finally, var-
iations were removed from the analysis when having a
missingness N 5% andHWE p-value b 1.0e−05, QC steps were conduct-
edwith PLINK (Chang et al., 2015). Variations in short insertions and de-
letions (indels) are difﬁcult to correctly detect with the short read
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ciation analysis (Ng et al., 2009).
2.7. Cytokines
Cytokines IL-6, TNF-α, IL1-β and IL-18 were determined in the CSF
collected from the diagnostic lumbar puncture. All analytes were mea-
sured with Luminex® xMAP® technology using Milliplex® map multi-
plex assay's (Millipore, Billerica) as descripted by Koopmans et al.
(Koopmans et al., 2014).
2.8. Residual Variation Intolerance Score (RVIS)
To evaluate if genes had more functional variation then expected
based on the neutral variations of that gene we calculated the RVIS of
each gene as described by Petrovski et al. (Petrovski et al., 2013). RVIS
calculations were performed with R (R, 2008).
2.9. Statistics
PLINKwas used for the single variation analysis (Chang et al., 2015).
We performed the Fisher exact-test for detecting allelic associations be-
tween groups. Variations were considered signiﬁcant when the False
Discovery Rate (FDR) adjusted p-value for the total number of tests
was below 0.05. We tested 1854 and 1385 variations for susceptibility
and outcome, respectively therefore p-values below 2.7e−05 and
3.6e−05 were statistically signiﬁcant.
For all MAF higher or equal to a frequency of 0.01% we reran the
analysis with a logistic regression including the ﬁrst ten MDS, to correct
for possible population stratiﬁcation, age and if the patients were im-
munosuppressed as covariates.
To study haplotype association, we used Haploview 4.2 (Barrett et
al., 2005). A total of 10,000 permutations were used to assess the p-
value of the haplotype using the build in function of Haploview 4.2.
All variations within the exons genes were tested with the adaptive
sum test of rare and common variant effects, as implemented in the Se-
quence Kernel Association Test (SKAT) (Ionita-Laza et al., 2013; Wu et
al., 2011). Tests were performedwith setting theminor allele frequency
(MAF) for rare variants on 0.05, 0.01 and the default setting. Bonferroni-
correction and False Discovery Rate (FDR) correction for 46 tests, equal
to the number of included genes, as implemented in the R package,
were applied for each SKAT generated p-value (R, 2008).
p-Values betweenmarker annotations of healthy controls, pneumo-
coccal meningitis patients and outcome were tested with the R built in
Chi-square test (R, 2008).
Cytokines level differences between genotypes were compared
using a Mann-Whitney U test.
3. Results
3.1. Clinical Characteristics of Pneumococcal Meningitis Patients
In this study we included 435 controls and 416 pneumococcal men-
ingitis patients. Median age of included patients was 61 years (inter-
quartile range 50–69) and 216 were female (50%). Upon discharge
146 (34%) had an unfavorable outcome (GOS 1 to 4) and 34 (8%) died.
3.2. Genetic Variation
Sequencing the exomes and ﬂanking regions of 46 innate immune
genes of 851 individuals resulted in 2099 variations after quality con-
trol. The majority of variations had a MAF below 0.01 (80%), indicating
that the variationwithin the innate immune genes had a lowprevalence
within the cohort. A total of 930 variations (44.3%) were found in only
one individual. The total presence of unique variations did not differ be-
tween meningitis patients and controls.Nonsense and frame-shift mutations leading to a premature stop
could lead to non-functional proteins of the transcript. Within our
individuals 12 variations were found that caused a stop in a total of
10 innate immune proteins (see Table 1). Compared to all variations,
there was no overrepresentation of stop-gained variations between
patients and healthy controls (p = 0.34) or between patients with
favorable and unfavorable outcome (p= 0.25). In relation to disease
susceptibility and outcome, one heterozygous stop-gained variation
in the IRAK 4 gene was observed in 4 patients who mainly had a fa-
vorable outcome (Table 1). Three other stop-gained variations
were found only within the group of patients with an unfavorable
outcome and were located in the CXCL8, TLR2 and TIRAP genes
(Table 1).
Genes can have more functional genetic variation altering the func-
tion of the protein. To evaluate the included 46 innate immune genes
we calculated the RVIS. The RVIS indicates the extent to which a gene
number of common functional mutations departure from genes with a
similar amount of mutations (Petrovski et al., 2013). Most common
functional variation was found in TLR5 and CARD8 had the least com-
mon functional variants (Fig. 1). When comparing distribution of func-
tional to all non-functional variants between patients and controls or
patients disease outcome we observed no differences (p = 0.75 and
p = 0.37).3.3. Pneumococcal Meningitis Susceptibility and Outcome Associated In-
nate Immune Markers
Results of the association study on the innate immune genetic vari-
ationwith susceptibility are shown in Table 2. Associationwasﬁrst test-
edwith theﬁsher exact test because of the highnumber of variantswith
a low MAF. The strongest signal was a T-variant in an intron of CARD8
(rs2008521), showing a higher frequency in cases compared to the con-
trols (OR 1.82, CI 1.28–2.75, p=8.2e−04). Preforming a logistic regres-
sion adjusted for population stratiﬁcation and age resulted in a p-value
of 6.1e−4 (OR 1.93, CI 1.33–2.81) for the CARD8 rs2008521 variation.
With the regression analysis a stronger signal is an A-variant located
in the intron of CXCL1 (rs56078309) (OR 1.96, CI 1.34–2.87, p =
8.2e−04). However, after correction for multiple testing, no associa-
tions reached signiﬁcance.
Haplotype associations for each gene showed no strong association
signals for pneumococcal susceptibility. Testing the genes for total var-
iation differences, with SKAT, based on all variations showed TLR5
(p = 0.03) as the strongest association and TLR3 (p = 0.03) when
weight on common and rare variations. With correction for multiple
testing these signals did not reach signiﬁcance.
Differences between allele frequencies within patients grouped on
outcome are shown in Table 3. The strongest signal, standing out com-
pared to the other signals, was a G-variant in the 3-prime UTR region
of IRAK4 (rs4251552) showing a higher frequency in patients with an
unfavorable outcome (OR 2.86, CI 1.58–5.18, p = 4.8e−04). Adjusting
for population stratiﬁcation, age and immunosuppression of the pa-
tients resulted in a p-value of 6.7e−04 (OR3.00, CI 1.59–5.66). When
applying this correction the strongest signal was a synonymous G-vari-
ation inNOD2 (rs2067085) (OR 2.16, CI 1.40–3.34, p= 5.1e−04). After
correcting for multiple testing the associations were no longer
signiﬁcant.
Haplotype association for IRAK4 showed a signiﬁcant association,
after correction for multiple testing, of one haplotype (p = 4.0e−04,
after 10,000 permutation test p = 0.004). This association is driven by
the IRAK4 rs4251552 variation, which was one of the strongest signals
in the single variation analyses (Fig. 2).
SKAT analysis based on all variations showed that PARP1 (p= 0.06)
as the strongest association and TICAM1 (p = 0.03) when weight on
common and rare variations. With correction for multiple testing
these signals did not reach signiﬁcance.
Table 1
STOP-Gained variations.
Chr Location Gene rs Codon Healthy
controls
Meningitis
patients
Favorable
outcome
Unfavorable
outcome
Stop-gained variations
1 223285200 TLR5 rs5744168 Arg/* 4 homozypotes
49 heterozygotes
2 homozypote
52 heterozygotes
2 homozypote
36 heterozygotes
16 heterozygotes
2 113888645 IL1RN rs121913161 Glu/* 1 heterozygote
3 38181977 MYD88 – Arg/* 1 heterozygote
4 74607285 CXCL8 rs188378669 Glu/* 1 heterozygote 1 heterozygote
4 154625126 TLR2 rs146476103 Ser/* 1 heterozygote 1 heterozygote
4 154625398 TLR2 rs62323857 Arg/* 3 heterozygotes 2 heterozygotes 1 heterozygotes 1 heterozygote
9 120475449 TLR4 – Leu/* 1 heterozygote 4 heterozygotes 3 heterozygotes 1 heterozygote
9 120476185 TLR4 rs5030720 1 heterozygote
11 126162878 TIRAP rs149490135 Arg/* 1 heterozygote 1 heterozygote
12 44172041 IRAK4 rs121908002 Gln/* 4 heterozygotes 3 heterozygotes 1 heterozygote
12 104333351 HSP90B1 – Ser/* 6 heterozygotes 4 heterozygotes 2 heterozygotes 2 heterozygotes
19 10394174 ICAM1 – Glu/* 5 heterozygotes 5 heterozygotes 2 heterozygotes 3 heterozygotes
80 B. Ferwerda et al. / EBioMedicine 10 (2016) 77–843.4. Effect of the Genetic Associations on CSF Cytokine Concentrations
From a subset of the patients we have measured the cytokines IL-6,
TNF-α, IL1-β and IL-18. For CARD8,NOD2 and IRAK4 it is known that de-
ﬁciencies in the gene alter the expression of someof these cytokines (Ko
et al., 2009; Ku et al., 2007; Ogura et al., 2001). CARD8 is a caspase re-
cruitment domain-containing protein involved in activation of caspases
leading to IL1-β and IL-18 cytokine production (Razmara et al., 2002).
IL1-β and IL-18 CSF measurements from pneumococcal meningitis pa-
tients showed no altered cytokine responses in different genotype
groups (Fig. 3a).NOD2 is involved in the recognition and innate immune
response against S. pneumoniae activating inﬂammatory cytokines, like
IL-6 and TNF-α through NF-κB activation (Opitz et al., 2004; Strober et
al., 2006). The associated NOD2 variation showed no difference in cyto-
kine CSF measurements grouped on their genotypes (Fig. 3b). IRAK4 is
the initial kinase near TLR receptors to activate downstream effectors,
such as the cytokines IL-6 and TNF-α, we studied these protein levels
in relation with genotype (Edwards and Chang, 1975). Cytokine mea-
surements from CSF in 175 patients showed that individuals with AG
or GG genotype had signiﬁcantly higher levels of IL-6 compared to indi-
viduals with AA genotype (median AA 75 ng/ml interquartile range
(IQR) 42–99vs. AG/GG 98 (IQR 85–99), p=0.04, Fig. 3c). No differences
in TNF-αwere observed.Fig. 1.Regression plot illustrating the regression of the sumof all common functional variants on
orange. Common has been set on a MAF of 1%. Most common functional variant tolerated (TLR3.5. Evaluating Known Invasive Pneumococcal Disease and Meningitis
Genetic Associations
Table 4 summarizes all genetic variations that we have sequenced
and is reported to be associated with either invasive pneumococcal dis-
ease (IPD) or meningitis. From the genes CARD8, IL-10, IRAK4, MAL,
MYD88, TLR2 and TLR4 a total of 10 variations could be replicated.
None of the variations showed a signiﬁcant association with pneumo-
coccal meningitis susceptibility or outcome.
4. Discussion
This study used full sequencing of the coding region and ﬂanking in-
tron boundaries of 46 innate immune genes frompneumococcalmenin-
gitis patients and healthy controls to search for genetic association with
susceptibility and disease outcome. We identiﬁed variations in CXCL1
(rs56078309) and CARD8 (rs2008521) as the strongest signals associat-
ed with susceptibility. Variations within the NOD2 (rs2067085) and
IRAK4 (rs4251552) were associated with pneumococcal meningitis dis-
ease outcome. Within the IRAK4 gene the found association rs4251552
deﬁned a haplotype that is signiﬁcantly associated with pneumococcal
disease outcome. Furthermore, pneumococcal meningitis patients
with the IRAK4 risk allele had higher levels of IL-6 in their CSF withall variants. Dashed lines indicate the 95% CI. Samples outside the 95% CI have been colored
5) and intolerant (CARD8) genes are colored purple.
Table 2
Top associations of sequenced variants with susceptibility to pneumococcal meningitis.
Chr Locationa rs Functionb Gene Alleles A1 frequency p-Value OR (±95 CI)
A1 A2 Cases Control Unadjusted FDRc
Susceptibility (Five highest Fisher exact test signals)
19 48715269 rs2008521, Intron CARD8 T C 0.115 0.067 8.2e−4 1 1.82 (1.28–2.57)
19 48711789 rs1968441 3_prime_UTR CARD8 T G 0.112 0.067 0.002 1 1.76 (1.24–2.48)
19 48711902 rs1968440 3_prime_UTR CARD8 A G 0.112 0.068 0.002 1 1.74 (1.23–2.46)
11 36510096 rs5030481 3_prime_UTR TRAF6 C T 0.029 0.009 0.003 1 3.44 (1.47–8.03)
4 74736180 rs56078309 Intron CXCL1 A G 0.112 0.070 0.003 1 1.68 (1.19–2.35)
Susceptibility (ﬁve highest logistic regression test signalsd)
4 74736180 rs56078309 Intron CXCL1 A G 0.112 0.070 4.8e−4 0.9 1.96 (1.34–2.87)
19 48715269 rs2008521, Intron CARD8 T C 0.115 0.067 6.1e−4 1 1.93 (1.33–2.81)
19 48711789 rs1968441 3_prime_UTR CARD8 T G 0.112 0.067 0.001 1 1.86 (1.28–2.70)
19 48711902 rs1968440 3_prime_UTR CARD8 A G 0.112 0.068 0.002 1 1.83 (1.26–2.65)
11 36510096 rs5030481 3_prime_UTR TRAF6 C T 0.029 0.009 0.002 1 4.69 (1.75–12.6)
a Location is based on GRCh37/hg19.
b The functional consequence of the variation or region of the gene transcript it is located.
c Adjusted p-value after False Discovery Rate (FDR) correction for type I errors.
d Analysis include the ﬁrst ten MDS and Age as covariates.
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increased pro-inﬂammatory response during their disease.
IRAK4 is a downstream TLR signaling protein and deﬁciency is a
known cause of recurrent pneumococcal disease (Picard et al., 2003;
Picard et al., 2010). IRAK4 deﬁcient PBMCs of patients have altered tran-
scription and impaired cytokine response after being activatedwith var-
ious TLR agonists and pathogens (Alsina et al., 2014; Ku et al., 2007). In
our four patients bearing a heterozygous stop-gained IRAK4 mutation
we did not ﬁnd any speciﬁc clinical characteristics. Deﬁciency of IRAK4
leads to dysfunctional TLR signaling and increased susceptibility. In con-
trast the observed increased IL-6 trend with the IRAK4 associated
rs4251552 displays the opposite picture with a stronger pro-inﬂamma-
tory response, which has been shown to be harmful for meningitis out-
come (Fig. 3) (Mook-Kanamori et al., 2011). The central role of the
IRAK4 gene during IPDmakes it a plausible candidate for adjuvant ther-
apies. Our ﬁndings indicate that these therapies have to focus on reduc-
ing the IRAK4 expression, or protein quantity, during the infection to
lower the inﬂammatory response.
Sequencing of 46 innate immune genes exomes all involved in pneu-
mococcal immune response did not result in many strong signals. After
correction for multiple testing none of the signals reached signiﬁcance
(Tables 2 and 3). Because of the uniqueness of our cohort we could
not replication our strongest signals in another pneumococcal meningi-
tis cohort. With this study we were able to look at the signals of varia-
tions previously associated IPD and pneumococcal meningitis.
Variations for CARD8, IL-10, IRAK4, MAL, MYD88, TLR2 and TLR4 genesTable 3
Top associations of sequenced variants with outcome of pneumococcal meningitis
Chr Locationa rs Functionb Gene Alleles
A1 A2
Disease outcome (ﬁve highest Fisher exact test signals)
12 44181141 rs4251552 3_prime_UTR IRAK4 G A
4 103497947 – Intron NFKB1 T A
11 36509357 rs5030508 3_prime_UTR TRAF6 T C
4 103497946 – Intron NFKB1 A T
22 22142954 rs56080243 Intron MAPK1 T C
Disease outcome (Five highest logistic regression test signalsd)
16 50733859 rs2067085 Synonymous NOD2 G A
12 44181141 rs4251552 3_prime_UTR IRAK4 G A
4 103497947 – Intron NFKB1 T A
11 36509357 rs5030508 3_prime_UTR TRAF6 T C
4 103497946 – Intron NFKB1 A T
a Location is based on GRCh37/hg19.
b The functional consequence of the variation or region of the gene transcript it is located.
c Adjusted p-value after False Discovery Rate (FDR) correction for type I errors.
d Analysis include the ﬁrst ten MDS, Age and immunosuppressed status as covariates.have been reported in association studies and were included in our
data (Carrasco-Colom et al., 2015; Ellis et al., 2015; Geldhoff et al.,
2013; Khor et al., 2007; Schaaf et al., 2003; van Well et al., 2013; van
Well et al., 2012; Yuan et al., 2008). None of the published variants
reach signiﬁcance within our analysis, even prior to correction for mul-
tiple testing (Table 4). Of these variations those in CARD8, TLR2 and TLR4
were reported to be associatedwith bacterialmeningitis (Geldhoff et al.,
2013; van Well et al., 2013; van Well et al., 2012). Lack of association
could be the result of the number of patients included in the studies
or grouping of different causal bacteria from the patients. The lack of as-
sociation forMYD88, IRAK4 and IKBKG is in line with the invasive pneu-
mococcal disease results of Ellis et al. (Ellis et al., 2015).
Neither single SNPs, haplotype nor burden analysis could show
strong associations. The lack of associations with variation in innate im-
munity genes, a known pathway involved in our defense against infec-
tion, could be the result of the evolutionary pressure on the innate
immune system. The innate immune system genes are subjected to pu-
rifying selection (Ferrer-Admetlla et al., 2008). Purifying selection is the
selective removal of alleles that are harmful because they alter the pro-
tein function signiﬁcantly (Karlsson et al., 2014). The ﬁnding of a higher
frequency of missense variations with a MAF b 0.01 could be the result
of this purifying selection that prevents them from gaining higher fre-
quency in the population. Despite the purifying selection it has been
shown that cell-surface expressed TLRs show relaxation of the selective
constraints leading to the increased presence of missense and stop-gain
mutations (Barreiro et al., 2009). In line with these relaxations weA1 frequency p-Value OR (±95 CI)
Unfavorable Favorable Unadjusted FDRc
0.095 0.035 4.8e−04 0.68 2.86 (1.58–5.18)
0.069 0.025 0.003 1 2.91 (1.45–5.82)
0.031 0.083 0.003 1 0.35 (0.17–0.72)
0.066 0.025 0.005 1 2.77 (1.37–5.60)
0.024 0.003 0.009 1 6.88 (1.42–33.32)
0.406 0.345 5.1e−04 0.71 2.16 (1.40–3.34)
0.095 0.035 6.7e−04 0.92 3.00 (1.59–5.66)
0.069 0.025 0.003 1 3.07 (1.45–6.50)
0.031 0.083 0.004 1 0.33 (0.16–0.71)
0.066 0.025 0.005 1 2.99 (1.39–6.40)
Fig. 2. IRAK4haplotypeswith a frequency of at least 1%. Signiﬁcant IRAK4haplotype (p=4.0e−04, after 10,000permutation test p=0.004) is outlined and the rs4251552 is highlighted in
yellow. Above all SNPs are the rs numbers and between parenthesis the functional annotation. Frequency of the haplotype was 0.095 in patients with unfavorable and 0.036 within the
favorable group.
Fig. 3. CSF protein cytokine levels of the CARD8 rs2043211NOD2 rs 2067085 and IRAK4 rs4251552 genotypes. Cytokines IL1-β, IL-18, IL-6 and TNF-αwere determinedwithin the CSF from
the diagnostic lumbar puncture samples taken from the patients. (a) Patients grouped on the CARD8 rs2043211 CC, TC and TT genotypes. For IL1-β there were 133 CC, 35 TC and 4 TT
patients and 131 CC, 35 TC and 3 TT for IL-18. (b) Patients grouped on their NOD2 rs206085 CC, CG and GG genotypes. For IL-6 and TNF-α 67 CC, 87 GC and 17 GG were included. (c)
Patients grouped on their IRAK4 rs4251552 AA and AG genotypes. IL-6 includes 159 AA and 16 AG patients and for TNF-α it were 158 AA and 16 AG patients. All data are summarized
as median and differences were tested using the Mann-Whitney U test.
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Table 4
Validation of genetic variants previously reported in invasive pneumococcal disease in the current pneumococcal meningitis cohort.
Chr Locationa rsb Functionc Gene p-Value OR (±95 CI) p-Value OR (±95 CI)
Case/control Outcome
Signals of reported IPD and meningitis associations
19 48737706 rs2043211 Missense CARD8d 0.98 1.01 (0.68–1.48) 0.09 1.65 (0.93–2.94)
1 206941864 rs3024496e 3_prime IL-10 0.31 1.18 (0.86–1.63) 0.47 1.19 (0.74–1.91)
12 44172041 rs121908002 Stop gained IRAK4 0.12f – 1f 0.64 (0.07–6.19)
12 44177511 rs55944915 Missense IRAK4 0.67 1.21 (0.50–2.92) 0.99 0.99 (0.28–3.56)
12 44180295 rs4251545 Missense IRAK4 0.11 1.33 (0.93–1.89) 0.38 1.26 (0.76–2.08)
11 126162843 rs8177374 Missense MAL 0.10 1.28 (0.95–1.72) 0.30 1.30 (0.86–1.98)
3 38184370 rs6853 3_prime MYD88 0.96 1.01 (0.74–1.37) 0.93 0.98 (0.62–1.55)
4 154626317 rs5743708 Missense TLR2 0.99 0.99 (0.62–1.62) 0.93 0.97 (0.48–1.98)
9 120475302 rs4986790 Missense TLR4 0.47 1.16 (0.78–1.72) 0.58 1.17 (0.67–2.03)
9 120475602 rs4986791 Missense TLR4 0.45 1.17 (0.78–1.76) 0.99 1.00 (0.56–1.79)
a Location is based on GRCh37/hg19.
b Variations have been reported in Carrasco-Colom et al. (2015), Ellis et al. (2015), van Well et al. (2012) and Yuan et al. (2008).
c The functional consequence of the variation or region of the gene transcript it is located.
d Additive model p-value = 0.5.
e SNP in linkage with the associated variation rs1800896 (upstream_gene_variant).
f Due to low frequency and only found in cases the Fisher exact test was used.
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the TLR5 (rs5744168), which can have high frequency within the popu-
lation (Table 1). The high frequency of rs5744168 has already been re-
ported and has been associated with altered susceptibility to
Legionnaires disease (Hawn et al., 2003). High RVIS of the TLR5 gene is
indicating that it contains the most functional common variations of
all included genes is in line with the relaxation of the selective con-
straints (Fig. 1). For all other stop-gained variations we only found
them at low frequency and in heterozygote state making it difﬁcult to
evaluate their effect on susceptibility and outcome.
Our study focusesmainly on the variation locatedwithin the protein
coding regions andmisses most of the genetic variations near the genes
involved in transcription regulation. Association studies in IPD also re-
ported variations in the nuclear factor of kappa light polypeptide gene
enhancer in B-cell inhibitors alpha (NFKBIA) and (NFKBIE) epsilon,
Toll-interleukin 1 receptor (TIRAP), interleukin cytokines IL-6, IL-10
and a macrophage migration inhibitory factor (MIF) microsatellite
(Chapman et al., 2007; Martin-Loeches et al., 2012; Schaaf et al., 2005;
Schaaf et al., 2003). All these variations are located upstream of the
genes and affect transcription and are not captured during exon se-
quencing, which is a limitation of our study.
A further limitation in our analysis on genetic variation and outcome
of disease is that treatment modalities varied per patient. The study is
observational and choice of treatment was at the discretion of the
treating physician. Because of the multitude of antibiotic regimens we
were unable to apply a correction for this. However, we think it is un-
likely this has a major inﬂuence on our results.
The number of individuals included in this study is the largest pneu-
mococcal meningitis cohort at this time. Results did not show many
strong associations, with high frequencies, that could be used as pneu-
mococcal meningitis risk markers for disease onset or progress. But
the association results do show which innate immune genes affected
by variation inﬂuence pneumococcal meningitis and point to import
hubs for treatment during the disease. The low frequency of most vari-
ations within the cohort makes it hard to detect associations. This was
not restricted to the single variant analysis, as the gene based mutation
burden analysis by SKAT also found no associations, when corrected for
multiple testing. Increasing the cohort size and replication of the most
signiﬁcant variants detected will eventually show whether these rare
variants contribute to pneumococcal meningitis susceptibility and
outcome.
CXCL1 (rs56078309) and CARD8 (rs2008521) variations were the
strongest associations for susceptibility. For disease outcome this were
the NOD2 (rs2067085) and IRAK4 (rs4251552) variations. For the
IRAK4 rs4251552 variation a trend of increased CSF IL-6 was observedfor patients with the risk allele. Because of the dominant role in the in-
nate immune signaling the ﬁnding that IRAK4 inﬂuences outcome
makes it a candidate for adjuvant therapies.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ebiom.2016.07.011.
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